Reporting of Palliative Sedation and Use of Opioids at the End of Life in a Belgian University Hospital: A Pilot Study

被引:3
|
作者
Marechal, Nicolas [1 ]
Six, Stefaan [2 ,3 ]
Clemmen, Eveline [4 ]
Baillon, Catherine [4 ]
Tack, Annelien [4 ]
Bauwens, Sabien [4 ]
Noppen, Marc [5 ]
Distelmans, Willem [4 ]
Beyer, Ingo [1 ]
Bilsen, Johan [2 ,3 ]
机构
[1] Univ Ziekenhuis Brussel, Vrije Univ Brussel, Dept Geriatr, Brussels, Belgium
[2] Vrije Univ Brussel, Dept Publ Hlth, Mental Hlth, Brussels, Belgium
[3] Vrije Univ Brussel, Wellbeing Res Grp, Brussels, Belgium
[4] Univ Ziekenhuis Brussel, Vrije Univ Brussel, Dept Support & Palliat Care, Brussels, Belgium
[5] Univ Ziekenhuis Brussel, Vrije Univ Brussel, Board Directors, Brussels, Belgium
关键词
end-of-life decisions; in-hospital mortality; opioids; palliative care; physician intention; CONTINUOUS DEEP SEDATION; EUTHANASIA; CARE;
D O I
10.1089/jpm.2021.0113
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Palliative sedation requires no formal registration in Belgium. For euthanasia, however, there are clear guidelines in certain countries, including mandatory registration and evaluation of cases. Official guidelines have been developed for palliative sedation, but research still shows unskilled use of sedation and unclear demarcation between palliative sedation and euthanasia. Registration could be used to avoid unskilled use of sedation and to avoid use or abuse of sedation to hasten the patient's death (described as "slow/passive euthanasia"). Objective: To evaluate the current practice of palliative sedation and use of opioids and sedatives at the end of life by using a registration document. Design: Retrospective observational study. Setting/Subjects: We included all in-hospital deaths at an academic hospital in Belgium of patients (age >= 18 years) who had received parenteral opioids, benzodiazepines, barbiturates, or other anesthetics during the last 24 hours. Measurements: We investigated indications for palliative sedation, patients' and physicians' characteristics, types of medication used, and the decision-making process with the patients and family. The questionnaires were collected between July 9 and November 25, 2016. The study was approved by the Biomedical Ethics Committee of UZ Brussel (B.U.N. 1432016293). Results: In a population of 124 patients, refractory symptoms were reported in 94.4%. All patients received parenteral opioids (intravenously). Benzodiazepines were used in 51.6%. In 75.8%, physicians reported no change in treatment plan during end of life. Hastening death by increasing analgesics and/or sedatives was mentioned in 19.3%. The treatment plan was discussed with patients in 26.6% of cases. In 6 cases, an explicit intention to hasten death was mentioned; in 36 cases, doses of opioids/sedatives may not have been strictly proportional to symptoms. Conclusion: This Belgian study shows that objective reporting of palliative sedation can be used as a tool to ensure good clinical practice where patients receive the most appropriate end-of-life care, avoiding abusive and injudicious or unskilled use of sedation.
引用
收藏
页码:742 / 748
页数:7
相关论文
共 50 条
  • [21] Palliative sedation at the end of life at a tertiary cancer center
    Augusto Caraceni
    Ernesto Zecca
    Cinzia Martini
    Giovanna Gorni
    Tiziana Campa
    Cinzia Brunelli
    Franco De Conno
    Supportive Care in Cancer, 2012, 20 : 1299 - 1307
  • [22] The use of opioids at the end-of-life and the survival of Egyptian palliative care patients with advanced cancer
    Alsirafy, Samy A.
    Galal, Khaled M.
    Abou-Elela, Enas N.
    Ibrahim, Noha Y.
    Farag, Dina E.
    Hammad, Ahmed M.
    ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (04) : 173 - 177
  • [23] Dexmedetomidine and Propofol at End of Life in Pediatric Oncology: Trends in Palliative Sedation Therapy
    Cuviello, Andrea
    Pasli, Melisa
    Bhatia, Shalini
    Johnson, Liza-Marie
    Anghelescu, Doralina L.
    Baker, Justin N.
    JOURNAL OF PALLIATIVE MEDICINE, 2023, 26 (01) : 79 - 86
  • [24] The role of end-of-life palliative sedation: medical and ethical aspects - Review
    Menezes, Miriam S.
    da Cruz de Assis Figueiredo, Maria das Gracas Mota
    REVISTA BRASILEIRA DE ANESTESIOLOGIA, 2019, 69 (01): : 72 - 77
  • [25] End-of-life chemotherapy use at a Finnish university hospital: a retrospective cohort study
    Rautakorpi, Liisa K.
    Seyednasrollah, Fatemeh
    Makela, Johanna M.
    Hirvonen, Outi M.
    Laitinen, Tarja
    Elo, Laura L.
    Jyrkkio, Sirkku M.
    ACTA ONCOLOGICA, 2017, 56 (10) : 1272 - 1276
  • [26] ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation
    Cherny, N. I.
    ANNALS OF ONCOLOGY, 2014, 25 : 143 - 152
  • [27] Sedation at the end of life - a nation-wide study in palliative care units in Austria
    Schur, Sophie
    Weixler, Dietmar
    Gabl, Christoph
    Kreye, Gudrun
    Likar, Rudolf
    Masel, Eva Katharina
    Mayrhofer, Michael
    Reiner, Franz
    Schmidmayr, Barbara
    Kirchheiner, Kathrin
    Watzke, Herbert Hans
    BMC PALLIATIVE CARE, 2016, 15
  • [28] Sedation at the end of life - a nation-wide study in palliative care units in Austria
    Sophie Schur
    Dietmar Weixler
    Christoph Gabl
    Gudrun Kreye
    Rudolf Likar
    Eva Katharina Masel
    Michael Mayrhofer
    Franz Reiner
    Barbara Schmidmayr
    Kathrin Kirchheiner
    Herbert Hans Watzke
    BMC Palliative Care, 15
  • [29] Sedatives and sedation at the end of life: a nursing home retrospective cohort study
    Schildmann, Eva
    Bolzani, Anna
    Meesters, Sophie
    Gruene, Bettina
    Marheineke, Alina
    Remi, Constanze
    Bausewein, Claudia
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2022, 12 (E6) : E744 - E747
  • [30] Serial Palliative Performance Scale Assessment in a University General Hospital: A Pilot Study
    de Medeiros, Rafael Barone
    Nunes de Faria Stamm, Ana Maria
    Moritz, Rachel Duarte
    Freitas, Paulo Fontoura
    Kretzer, Lara Patricia
    Gomes, Juliana Vieira
    JOURNAL OF PALLIATIVE MEDICINE, 2018, 21 (06) : 842 - 845